These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 28495384)

  • 1. Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine.
    da Silva VBR; Campos BRKL; de Oliveira JF; Decout JL; do Carmo Alves de Lima M
    Bioorg Med Chem; 2017 Jul; 25(13):3259-3277. PubMed ID: 28495384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effect of oxamniquine, praziquantel and a combination of both drugs on the intramolluscan phase of Schistosoma mansoni.
    Mattos AC; Pereira GC; Jannotti-Passos LK; Kusel JR; Coelho PM
    Acta Trop; 2007 May; 102(2):84-91. PubMed ID: 17498638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis.
    Alwan SN; Taylor AB; Rhodes J; Tidwell M; McHardy SF; LoVerde PT
    PLoS Pathog; 2023 Jul; 19(7):e1011018. PubMed ID: 37428793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schistosomiasis: Drugs used and treatment strategies.
    Siqueira LDP; Fontes DAF; Aguilera CSB; Timóteo TRR; Ângelos MA; Silva LCPBB; de Melo CG; Rolim LA; da Silva RMF; Neto PJR
    Acta Trop; 2017 Dec; 176():179-187. PubMed ID: 28803725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel.
    Bonesso-Sabadini PI; de Souza Dias LC
    Mem Inst Oswaldo Cruz; 2002 Apr; 97(3):381-5. PubMed ID: 12048569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.
    Fallon PG; Doenhoff MJ
    Am J Trop Med Hyg; 1994 Jul; 51(1):83-8. PubMed ID: 8059919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for hycanthone drug action in schistosome parasites.
    Guzman M; Rugel A; Tarpley RS; Cao X; McHardy SF; LoVerde PT; Taylor AB
    Mol Biochem Parasitol; 2020 Mar; 236():111257. PubMed ID: 32027942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferrocenyl, Ruthenocenyl, and Benzyl Oxamniquine Derivatives with Cross-Species Activity against Schistosoma mansoni and Schistosoma haematobium.
    Hess J; Panic G; Patra M; Mastrobuoni L; Spingler B; Roy S; Keiser J; Gasser G
    ACS Infect Dis; 2017 Sep; 3(9):645-652. PubMed ID: 28686009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An iterative process produces oxamniquine derivatives that kill the major species of schistosomes infecting humans.
    Guzman MA; Rugel AR; Tarpley RS; Alwan SN; Chevalier FD; Kovalskyy DP; Cao X; Holloway SP; Anderson TJC; Taylor AB; McHardy SF; LoVerde PT
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008517. PubMed ID: 32810153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidisciplinary Preclinical Investigations on Three Oxamniquine Analogues as New Drug Candidates for Schistosomiasis*.
    Buchter V; Ong YC; Mouvet F; Ladaycia A; Lepeltier E; Rothlisberger U; Keiser J; Gasser G
    Chemistry; 2020 Nov; 26(66):15232-15241. PubMed ID: 32852116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of tegumental damage to Schistosoma mansoni and S. haematobium after in vitro exposure to ferrocenyl, ruthenocenyl and benzyl derivatives of oxamniquine using scanning electron microscopy.
    Buchter V; Hess J; Gasser G; Keiser J
    Parasit Vectors; 2018 Nov; 11(1):580. PubMed ID: 30400935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the antioxidant defence in different developmental stages of Schistosoma mansoni by praziquantel and artemether.
    El-Bassiouni EA; Helmy MH; Saad EI; El-Nabi Kamel MA; Abdel-Meguid E; Hussein HS
    Br J Biomed Sci; 2007; 64(4):168-74. PubMed ID: 18236739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium.
    Kovač J; Vargas M; Keiser J
    Parasit Vectors; 2017 Aug; 10(1):365. PubMed ID: 28764732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a method for induction of praziquantel resistance in Schistosoma mansoni.
    Lotfy WM; Hishmat MG; El Nashar AS; Abu El Einin HM
    Pharm Biol; 2015 Aug; 53(8):1214-9. PubMed ID: 25609146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could we expect new praziquantel derivatives? A meta pharmacometrics/pharmacoinformatics analysis of all antischistosomal praziquantel derivatives found in the literature.
    da Silva VBR; Boucherle B; El-Methni J; Hoffmann B; da Silva AL; Fortune A; de Lima MDCA; Thomas A
    SAR QSAR Environ Res; 2019 Jun; 30(6):383-401. PubMed ID: 31144535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfiram and dithiocarbamate analogues demonstrate promising antischistosomal effects.
    Rennar GA; Gallinger TL; Mäder P; Lange-Grünweller K; Haeberlein S; Grünweller A; Grevelding CG; Schlitzer M
    Eur J Med Chem; 2022 Nov; 242():114641. PubMed ID: 36027862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model.
    Abla N; Keiser J; Vargas M; Reimers N; Haas H; Spangenberg T
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005942. PubMed ID: 28934207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of chiral praziquantel analogues as potential drug candidates with activity to juvenile Schistosoma japonicum.
    Zheng Y; Dong L; Hu C; Zhao B; Yang C; Xia C; Sun D
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4223-6. PubMed ID: 25127102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of oxamniquine praziquantel and clonazepam in experimental Schistosomiasis mansoni.
    Araujo N; Mattos AC; Coelho PM; Katz N
    Mem Inst Oswaldo Cruz; 2008 Dec; 103(8):781-5. PubMed ID: 19148417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
    Liu LX; Li-Li J; Qiong C; Xiao-Lin F
    Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.